Analyst Price Targets — ALDX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| October 8, 2025 4:49 pm | Clara Dong | Jefferies | $7.00 | $5.62 | TheFly | Aldeyra price target raised to $7 from $6 at Jefferies |
| October 3, 2024 9:30 am | Justin Kim | Oppenheimer | $12.00 | $5.14 | StreetInsider | Oppenheimer Reiterates Outperform Rating on Aldeyra Therapeutics (ALDX) |
| April 3, 2024 7:08 am | Justin Kim | Oppenheimer | $10.00 | $3.55 | StreetInsider | Oppenheimer Upgrades Aldeyra Therapeutics (ALDX) to Outperform |
| April 2, 2024 6:08 am | Matt Caufield | H.C. Wainwright | $10.00 | $3.27 | StreetInsider | H.C. Wainwright Reinstates Aldeyra Therapeutics (ALDX) at Buy |
Latest News for ALDX
NEW YORK, April 19, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Aldeyra To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Aldeyra between November 3, 2023 and March 16, 2026 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may…
New York, New York--(Newsfile Corp. - April 18, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased…
NEW YORK, April 18, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the “Class Period”), of the important May 29, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.
New York, New York--(Newsfile Corp. - April 17, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ALDX.
U.S. House Trading
No House trades found for ALDX.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.